These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 26597827)

  • 21. Hypercalcemia associated with infection by Cryptococcus neoformans and Coccidioides immitis.
    Ali MY; Gopal KV; Llerena LA; Taylor HC
    Am J Med Sci; 1999 Dec; 318(6):419-23. PubMed ID: 10616168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of vitamin D drops leading to kidney failure in a 54-year-old man.
    Auguste BL; Avila-Casado C; Bargman JM
    CMAJ; 2019 Apr; 191(14):E390-E394. PubMed ID: 30962197
    [No Abstract]   [Full Text] [Related]  

  • 23. Successful treatment of aggressive HIV-associated multicentric Castleman's disease: a case report.
    Flejsierowicz M; Ahmed MS; Kotov P; Cheng YC
    WMJ; 2008 Jul; 107(4):191-4. PubMed ID: 18702436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypercalcemia in patients with disseminated coccidioidomycosis.
    Caldwell JW; Arsura EL; Kilgore WB; Reddy CM; Johnson RH
    Am J Med Sci; 2004 Jan; 327(1):15-8. PubMed ID: 14722391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin D and cancer mini-symposium: the risk of additional vitamin D.
    Vieth R
    Ann Epidemiol; 2009 Jul; 19(7):441-5. PubMed ID: 19364661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute vitamin D intoxication possibly due to faulty production of a multivitamin preparation.
    Anık A; Çatlı G; Abacı A; Dizdarer C; Böber E
    J Clin Res Pediatr Endocrinol; 2013; 5(2):136-9. PubMed ID: 23748070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin D-mediated hypercalcemia as the initial manifestation of pulmonary cryptococcosis in an HIV-uninfected patient.
    Huang JC; Kuo MC; Hwang SJ; Hwang DY; Chen HC
    Intern Med; 2012; 51(13):1793-6. PubMed ID: 22790148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitamin D metabolism in familial benign hypercalcemia (hypocalciuric hypercalcemia) differs from that in primary hyperparathyroidism.
    Law WM; Bollman S; Kumar R; Heath H
    J Clin Endocrinol Metab; 1984 Apr; 58(4):744-7. PubMed ID: 6699136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypercalcemia and elevated serum 1,25-dihydroxyvitamin D3 in a patient with Hodgkin's lymphoma.
    Schaefer K; Saupe J; Pauls A; von Herrath D
    Klin Wochenschr; 1986 Jan; 64(2):89-91. PubMed ID: 3754025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infantile hypercalcemia and hypercalciuria: new insights into a vitamin D-dependent mechanism and response to ketoconazole treatment.
    Nguyen M; Boutignon H; Mallet E; Linglart A; Guillozo H; Jehan F; Garabedian M
    J Pediatr; 2010 Aug; 157(2):296-302. PubMed ID: 20394945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitamin D metabolite-mediated hypercalcemia in Wegener's granulomatosis.
    Bosch X; López-Soto A; Morelló A; Olmo A; Urbano-Márquez A
    Mayo Clin Proc; 1997 May; 72(5):440-4. PubMed ID: 9146687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alleviation of systemic manifestations of multicentric Castleman's disease by thalidomide.
    Lee FC; Merchant SH
    Am J Hematol; 2003 May; 73(1):48-53. PubMed ID: 12701121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Castleman's disease and sarcoidosis, a rare association resulting in a "mixed" response: a case report.
    Mohammed A; Janku F; Qi M; Kurzrock R
    J Med Case Rep; 2015 Feb; 9():45. PubMed ID: 25884809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary hyperparathyroidism and severe hypercalcemia with low circulating 1,25-dihydroxyvitamin D.
    Shaker JL; Krawczyk KW; Findling JW
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1305-9. PubMed ID: 2229288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin D toxicity due to a commonly available "over the counter" remedy from the Dominican Republic.
    Lowe H; Cusano NE; Binkley N; Blaner WS; Bilezikian JP
    J Clin Endocrinol Metab; 2011 Feb; 96(2):291-5. PubMed ID: 21123442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe hypercalcemia following vitamin d supplementation in a patient with multiple sclerosis: a note of caution.
    Marcus JF; Shalev SM; Harris CA; Goodin DS; Josephson SA
    Arch Neurol; 2012 Jan; 69(1):129-32. PubMed ID: 22232355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypercalcemia, hypervitaminosis A and 3-epi-25-OH-D3 levels after consumption of an "over the counter" vitamin D remedy. a case report.
    Granado-Lorencio F; Rubio E; Blanco-Navarro I; Pérez-Sacristán B; Rodríguez-Pena R; García López FJ
    Food Chem Toxicol; 2012 Jun; 50(6):2106-8. PubMed ID: 22426357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypercalcemia due to endogenous overproduction of active vitamin D in identical twins with cat-scratch disease.
    Bosch X
    JAMA; 1998 Feb; 279(7):532-4. PubMed ID: 9480364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypercalcemia of malignancy with simultaneous elevation in serum parathyroid hormone--related peptide and 1,25-dihydroxyvitamin D in a patient with metastatic renal cell carcinoma.
    Shivnani SB; Shelton JM; Richardson JA; Maalouf NM
    Endocr Pract; 2009 Apr; 15(3):234-9. PubMed ID: 19364692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypercalcemia secondary to leprosy.
    Couri CE; Foss NT; Dos Santos CS; de Paula FJ
    Am J Med Sci; 2004 Dec; 328(6):357-9. PubMed ID: 15599334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.